Kwangdong Pharmaceutical Promotes Sangyoung Park to President and Chief Operating Officer

Giryong Bae Promoted to Executive Director as Head of Division
Daeseok Jung Newly Appointed as Managing Director and Head of Division

Kwangdong Pharmaceutical announced on November 13 that it has promoted Sangyoung Park, Executive Vice President, to President and Chief Operating Officer, promoted Giryong Bae, Managing Director, to Executive Director, and newly appointed Daeseok Jung, Head of Human Resources Planning Division, as Managing Director.

From the left in the photo, Sangyoung Park, President (Chief Operating Officer), Giryong Bae, Executive Director (Head of Pharmaceutical Research and Development Division), Daeseok Jung, Managing Director (Head of Human Resources Planning Division). Kwangdong Pharmaceutical

Photo by Kwangdong Pharmaceutical

This executive reshuffle is seen as a strategic decision aimed at securing sustainable new growth engines based on a stable management foundation, and focusing capabilities on enhancing shareholder value and external credibility. In particular, the company plans to further strengthen organizational competitiveness by expanding its R&D new drug development pipeline and advancing its human resource management system.

President Sangyoung Park will oversee overall management activities as Chief Operating Officer. Park has previously served as Chief Safety and Environment Officer (CSEO) and Head of Communications, overseeing media relations, ESG, legal affairs, and audit work, while strengthening safety and environmental management and both internal and external communications. Going forward, he will lay the foundation for the company’s long-term growth by establishing a sustainable management system and ensuring management stability.

Executive Director Giryong Bae, as Head of the Pharmaceutical Research and Development Division, will accelerate R&D innovation and continue to expand the new drug development pipeline. Bae has contributed to discovering new growth engines by establishing partnerships with leading global pharmaceutical companies and introducing a series of innovative products, including treatments for rare diseases and gene therapies. Managing Director Daeseok Jung, newly appointed as an executive, will oversee human resources strategy as Head of the Human Resources Planning Division, leading the enhancement of organizational capabilities and the advancement of the human resource management system.

This content was produced with the assistance of AI translation services.